Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

carfilzomib

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

Proteasome inhibitor

Related drugs:

‹

bortezomib (90)

bortezomib (90)

›

No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	carfilzomib Sensitive: A1 - Approval carfilzomib Sensitive : A1	carfilzomib Sensitive: A1 - Approval carfilzomib Sensitive : A1
No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	lenalidomide + carfilzomib Sensitive: A1 - Approval lenalidomide + carfilzomib Sensitive : A1	lenalidomide + carfilzomib Sensitive: A1 - Approval lenalidomide + carfilzomib Sensitive : A1
No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	selinexor + carfilzomib Sensitive: A2 - Guideline selinexor + carfilzomib Sensitive : A2	selinexor + carfilzomib Sensitive: A2 - Guideline selinexor + carfilzomib Sensitive : A2
No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	carfilzomib + pomalidomide Sensitive: A2 - Guideline carfilzomib + pomalidomide Sensitive : A2	carfilzomib + pomalidomide Sensitive: A2 - Guideline carfilzomib + pomalidomide Sensitive : A2
CD27 expression	Multiple Myeloma	CD27 expression	Multiple Myeloma	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3
TMPRSS11E expression	Multiple Myeloma	TMPRSS11E expression	Multiple Myeloma	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3
STRA6 expression	Multiple Myeloma	STRA6 expression	Multiple Myeloma	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3
CLEC7A expression	Multiple Myeloma	CLEC7A expression	Multiple Myeloma	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3
LPXN expression	Multiple Myeloma	LPXN expression	Multiple Myeloma	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3
GPR176 expression	Multiple Myeloma	GPR176 expression	Multiple Myeloma	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3
TK1 expression	Multiple Myeloma	TK1 expression	Multiple Myeloma	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3	carfilzomib Sensitive: C3 – Early Trials carfilzomib Sensitive : C3
Chr t(11;14)(q13;q32)	Multiple Myeloma	Chr t(11;14)(q13;q32)	Multiple Myeloma	carfilzomib Resistant: C4 – Case Studies carfilzomib Resistant : C4	carfilzomib Resistant: C4 – Case Studies carfilzomib Resistant : C4